Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Cathelicidin and Vitamin D: Impact on Populations At-Risk and With COPD [Phase 2]
Phase 2 clinical trial assessing cathelicidin and vitamin D effects in at-risk populations and individuals with chronic obstructive pulmonar…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)
A completed clinical trial analyzing duration of use of two inhaler types with different medicines in COPD patients; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: Stratified TreAtment to Reduce Risk in COPD [Phase 4]
Phase 4 clinical trial updating stratified treatment to reduce risk in COPD exacerbations has been completed.
-
CLINICAL_TRIALS trial_result · 2020-07-21Clinical Trial Update: Effects of an mHealth Web-Based Platform (HappyAir) on Adherence to a Maintenance Program After Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating the impact of a mobile health web-based platform (HappyAir) on adherence to a maintenance progra…
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: INvestigating COPD Outcomes, Genomics and Neutrophilic Inflammation With Tiotropium and Olodaterol [Phase 4]
Phase 4 clinical trial update evaluating tiotropium and olodaterol for COPD outcomes, genomics, and neutrophilic inflammation.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-06-29Clinical Trial Update: HFNC Effect on BCSS in Patients With COPD [NA]
Clinical trial update on high-flow nasal cannula (HFNC) effect on BCSS in COPD patients; study terminated with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Pulmonary Rehabilitation Before Lung Cancer Resection [Phase 3]
A Phase 3 trial evaluating pulmonary rehabilitation before lung cancer resection in patients with non-small cell lung cancer (and COPD) has …
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: Imaging Regional Lung Defect Severity [Phase 1, Phase 2]
A Phase 1/2 clinical trial in COPD has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment [Phase 4]
Phase 4 trial comparing Tiotropium/Formoterol via Discair with Tiotropium monotherapy or Tiotropium plus Formoterol free combination in COPD…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Assessment of Bronchodilator Efficacy of Formoterol/Budesonide 12/400 mcg Via Discair in COPD [Phase 4]
Phase 4 trial update assessing bronchodilator efficacy of formoterol/budesonide 12/400 mcg via Discair in COPD.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Comparison of 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in Patients With Moderate to Severe COPD [Phase 4]
Phase 4 trial comparing 24-hour bronchodilator efficacy of tiotropium delivered via DISCAIR versus HANDIHALER in moderate to severe COPD.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease [Phase 4]
Phase 4 clinical trial update evaluating the effect of STIOLTO RESPIMAT on fatigue in chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: Efficacy and Safety Study of Acetylcysteine/Doxofylline 1200/400 mg Effervescent Tablet in the Treatment of Moderate-Severe COPD. [Phase 4]
Phase 4 trial evaluating the efficacy and safety of acetylcysteine/doxofylline 1200/400 mg effervescent tablets for moderate-to-severe COPD.
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: Tiotropium/Salmeterol/Fluticasone Fixed Dose Combination Tratment Via Discair vs Tiotropium Via Handihaler + Salmeterol/Fluticasone Via Diskus Free Combination Treatment [Phase 4]
Phase 4 trial comparing a fixed-dose combination inhaler (tiotropium/salmeterol/fluticasone) to separate tiotropium plus salmeterol/fluticas…
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010 [Phase 1]
Phase 1 randomized crossover study in healthy subjects to assess relative bioavailability of PT010; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Study to Demonstrate That Antibiotics Are Not Needed in Moderate Acute Exacerbations of COPD [Phase 4]
A Phase 4 trial evaluating whether antibiotics are unnecessary in moderate acute exacerbations of COPD has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler® [Phase 3]
Phase 3 trial assessing PT010, PT003, and PT009 versus Symbicort in Japanese subjects with COPD; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-05-08Clinical Trial Update: A Study to Assess the PK and Safety of PT010 in Subjects With COPD Following Single and Repeat Dose [Phase 1]
Phase 1 study assessing pharmacokinetics and safety of PT010 in subjects with COPD; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-07Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366 [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of CHF6366 in healthy volunteers and in ast…
-
CLINICAL_TRIALS trial_result · 2020-04-27Clinical Trial Update: Greek NIS Spiolto ELLACTO
Clinical trial update for the Spiolto EllACTO study in COPD has completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial comparing FF/UMEC/VI single inhaler triple therapy to tiotropium alone in COPD patients; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-16Clinical Trial Update: The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus [Phase 4]
A Phase 4 study comparing tiotropium/olodaterol (Stiolto) inhaled via Respimat vs fluticasone/salmeterol (Advair) via Diskus in COPD; study …
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: BACE Trial Substudy 1 - PROactive Substudy [Phase 3]
Phase 3 BACE Trial Substudy 1 PROactive Substudy completed for chronic obstructive pulmonary disease.
-
CLINICAL_TRIALS trial_result · 2020-04-08Clinical Trial Update: BACE Trial Substudy 2 - FarmEc Substudy [Phase 3]
Phase 3 trial update for a BACE-related substudy (FarmEc) in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)
A completed clinical trial evaluating health and functional status changes in COPD patients during therapy with Spiolto Respimat (AERIAL).